Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending January 11, 2020 (Week 02)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2020 †Cum YTD 2019 †Current weekPrevious 52 weeks Max †Cum YTD 2020 †Cum YTD 2019 †
U.S. Residents, excluding U.S. Territories 358 552 754 1,087 11 10 19 16
New England 6 45 14 80 - 2 - 1
Connecticut - 14 - 16 - 0 - -
Maine 2 9 9 13 - 0 - -
Massachusetts - 23 - 38 - 2 - -
New Hampshire - 10 1 9 - 1 - -
Rhode Island - 8 - 2 - 1 - -
Vermont 4 4 4 2 - 1 - 1
Middle Atlantic 50 109 111 127 3 4 4 1
New Jersey 4 26 20 46 - 3 1 1
New York (excluding New York City) 21 81 21 18 3 2 3 -
New York City 25 29 65 50 - 3 - -
Pennsylvania - 9 5 13 - 1 - -
East North Central 71 132 175 232 7 5 12 4
Illinois N NC N N N NC N N
Indiana 5 25 14 42 - 1 - -
Michigan 3 34 18 60 - 3 - -
Ohio 55 67 118 109 7 3 12 4
Wisconsin 8 19 25 21 - 0 - -
West North Central 25 45 65 78 - 5 1 7
Iowa N NC N N N NC N N
Kansas - 11 - 13 - 1 - 1
Minnesota - 12 - - - 0 - -
Missouri 16 26 47 48 - 4 1 5
Nebraska 8 9 16 10 - 1 - -
North Dakota - 4 - 3 - 0 - -
South Dakota 1 6 2 4 - 2 - 1
South Atlantic 79 95 122 174 1 3 1 1
Delaware - 6 - 4 - 0 - -
District of Columbia - 5 - 2 - 0 - -
Florida 62 42 81 35 1 2 1 -
Georgia 3 33 6 59 - 0 - -
Maryland 13 19 31 26 - 1 - -
North Carolina N NC N N N NC N N
South Carolina - 20 - 31 - 2 - 1
Virginia - 3 1 1 - 0 - -
West Virginia 1 17 3 16 - 0 - -
East South Central 54 96 112 155 - 2 - 1
Alabama 2 25 7 43 - 1 - -
Kentucky 13 19 31 21 - 1 - -
Mississippi 20 19 32 33 - 0 - -
Tennessee 19 38 42 58 - 2 - 1
West South Central 20 143 23 57 - 4 - -
Arkansas 10 28 10 8 - 0 - -
Louisiana - 20 - 17 - 1 - -
Oklahoma N NC N N N NC N N
Texas 10 115 13 32 - 4 - -
Mountain 53 96 128 174 - 2 1 1
Arizona 29 35 61 66 - 1 1 -
Colorado 16 23 39 31 - 1 - -
Idaho N NC N N N NC N N
Montana - 8 - 6 - 1 - -
Nevada - 19 3 22 - 0 - -
New Mexico 5 19 12 33 - 0 - -
Utah 2 12 11 15 - 1 - 1
Wyoming 1 4 2 1 - 0 - -
Pacific - 11 4 10 - 1 - -
Alaska - 6 - 6 - 1 - -
California N NC N N N NC N N
Hawaii - 8 4 4 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 358 552 754 1,087 11 10 19 16
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.